Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2001
04/12/2001WO2000065055A3 Human transporter proteins
04/12/2001WO2000064938A3 Peptide homodimers or peptide heterodimers derived from interleukin 12
04/12/2001WO2000064489A3 Diagnostic marker for the human heart
04/12/2001WO2000061755A3 Secreted human proteins
04/12/2001WO2000061735A8 Modification of plant storage reserves
04/12/2001WO2000061615A3 Homologs of mar-binding filament-like protein 1 (mfp1)
04/12/2001WO2000046380A3 Fibroblast growth factor receptor-immunoglobulin fusion
04/12/2001WO2000039289A3 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen
04/12/2001WO2000036087A9 Nucleolus autoantigenic marker for systematic lupus erythematosus
04/12/2001WO2000006199A8 Kvlqt1 - a long qt syndrome gene
04/12/2001WO2000000616A9 Marburg virus vaccines
04/12/2001WO1999050284A3 Nucleic acid molecules which code proteins influencing bone development
04/12/2001WO1997020056A3 Enhancer-increased gene expression in plants
04/12/2001WO1997012524A3 Method of processing protein-containing plants
04/12/2001WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses
04/12/2001US20010000241 A polynucleotide of either: (a) a polynucleotide encoding the SEQ ID NO:2; (b) a polynucleotide encoding a mature polypeptide encoded by the DNA contained in an ATCC deposit; a hybridizing polynucleotides; polypeptide receptor ligands
04/12/2001DE19947792A1 Neue für das Irp Gen codierende Nukleotidsequenzen New gene nucleotide sequences coding for the Irp
04/12/2001CA2406882A1 Diagnostic probes and therapeutics targeting upa and upar
04/12/2001CA2391805A1 Differentially expressed genes associated with her-2/neu overexpression
04/12/2001CA2388533A1 Utrophin gene promoter
04/12/2001CA2387686A1 Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination
04/12/2001CA2386854A1 Methods of using a mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of heterologous proteins
04/12/2001CA2386841A1 Fusion proteins of mycobacterium tuberculosis
04/12/2001CA2386533A1 Use of soluble costimulatory factor for tumor immuno-gene therapy
04/12/2001CA2386499A1 Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
04/12/2001CA2386465A1 Compositions and methods for tumor-targeted delivery of effector molecules
04/12/2001CA2386383A1 Growth factor polypeptides and nucleic acids encoding same
04/12/2001CA2386377A1 Cell targeting compositions and methods of using the same
04/12/2001CA2386252A1 Splice variant of head trauma induced cytoplasmatic calcium binding protein
04/12/2001CA2386248A1 Il13 mutants
04/12/2001CA2386237A1 Improved ricin-like toxins for treatment of cancer
04/12/2001CA2386236A1 Human inwardly rectifying potassium channel subunit
04/12/2001CA2386199A1 Endozepine-like polypeptides and polynucleotides encoding same
04/12/2001CA2386192A1 C-myc antisense-treated hematopoietic stem cell composition and method
04/12/2001CA2386189A1 Novel human membrane proteins
04/12/2001CA2386089A1 Diagnostic and therapeutic epitope and transgenic plant
04/12/2001CA2385984A1 Animal model for mesangial proliferative nephritis
04/12/2001CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies
04/12/2001CA2385551A1 Metal-binding compounds and uses therefor
04/12/2001CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use
04/12/2001CA2385045A1 Ifn-alpha homologues
04/12/2001CA2385032A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
04/12/2001CA2384696A1 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen
04/12/2001CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
04/12/2001CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
04/12/2001CA2379462A1 Human g-protein coupled receptor
04/12/2001CA2348780A1 Regulatory/unfolding peptides of ezrin
04/11/2001EP1090999A2 Plant with modified flowers
04/11/2001EP1090996A1 Vector expressing the full-length gene of rna virus and use thereof
04/11/2001EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof
04/11/2001EP1090994A2 Peptide repeat immunogens
04/11/2001EP1090993A1 Nucleotide sequences coding for the lrp gene
04/11/2001EP1090992A1 NOVEL POLYPEPTIDE, cDNA ENCODING THE SAME AND UTILIZATION THEREOF
04/11/2001EP1090991A1 Novel nicotinic acetylcholine receptor subunit, its isolation and use
04/11/2001EP1090990A1 Human g-protein-coupled receptor
04/11/2001EP1090989A1 Human g-protein-coupled receptor
04/11/2001EP1090987A1 Cell cycle regulatory factor
04/11/2001EP1090986A1 Protein rim 2
04/11/2001EP1090926A1 Human G-protein coupled receptor
04/11/2001EP1090925A1 Human G-protein coupled receptor
04/11/2001EP1090668A1 Chelate-forming filter, process for producing the same, and method of purifying liquid with the filter
04/11/2001EP1090641A2 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
04/11/2001EP1090640A2 Insulin analog formulations
04/11/2001EP1090294A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
04/11/2001EP1090142A1 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith
04/11/2001EP1090132A1 Methods for production of recombinant polypeptides
04/11/2001EP1090122A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
04/11/2001EP1090121A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms
04/11/2001EP1090120A2 Propionibacterium vector
04/11/2001EP1090119A2 Novel olfactory receptors and their uses
04/11/2001EP1090118A2 Human signal peptide-containing proteins
04/11/2001EP1090117A2 Differentially expressed genes in pancreatic cancer and displasia
04/11/2001EP1090116A2 Transgenic non-human animal which comprises an inactive peg3 gene, and the use thereof
04/11/2001EP1090112A1 Human arf-related proteins
04/11/2001EP1090110A2 Human vault rna
04/11/2001EP1090106A2 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
04/11/2001EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
04/11/2001EP1090036A2 Site specific protein modification by mutagenesis
04/11/2001EP1090035A1 A spray-dried bacteriocin powder with anti-microbial activity
04/11/2001EP1090034A2 Novel staphylococcus peptides for bacterial interference
04/11/2001EP1090033A1 Particles of hcv envelope proteins: use for vaccination
04/11/2001EP1090032A2 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
04/11/2001EP1089794A2 Methods for inhibiting tef-3 activity
04/11/2001EP1089759A1 Synthetic peptide vaccines for foot-and-mouth disease
04/11/2001EP1089758A1 Mucosal targeting immunisation
04/11/2001EP1089757A1 Hla binding peptides and their uses
04/11/2001EP1089755A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
04/11/2001EP0963203A4 Mammalian tolloid-like gene and protein
04/11/2001EP0900282A4 Ob receptor isoforms and nucleic acids encoding them
04/11/2001EP0897391A4 Recombinant antigens useful for the serodiagnosis of neosporosis
04/11/2001EP0876492A4 Novel methods for the characterization of compounds which stimulate stf-1 expression in pancreatic islet cells
04/11/2001EP0871762A4 Hp-8 autoantigen
04/11/2001EP0800585B1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
04/11/2001EP0733108B1 Mutants of bone morphogenetic proteins
04/11/2001EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation
04/11/2001EP0517829B1 Improved chimeric toxins
04/11/2001CN1291235A Vaccines immunotherapeutics and method for using the same
04/11/2001CN1291231A Human telomerase catalytic subunit
04/11/2001CN1291230A Biotin-binding receptor molecules
04/11/2001CN1291229A Recombinant active human zona pellucida protein 3 (h2P3)